Omkar Pharmachem Ltd manufactures chemicals used in pharmaceuticals.Product Profile: a) Sodium bi-sulphite b) Sodium meta bi-sulphite c) Sodium sulphite d) Sulphur e) Specialty chemicals f) Ciba specialty chemicals g) Organic chemicals
Here is a summary of the announcements from the document: **Omkar Pharmachem Limited:** Omkar Pharmachem Limited has announced the financial results for the quarter. Total income from operations stood at 0.14 Cr, with a net profit after tax of 0.03 Cr for the period. Earnings per share (Basic & Diluted)...
Omkar Pharmachem has announced a board meeting to consider the financial results for the quarter and half-year. The company received a confirmation certificate from its Registrar and Share Transfer Agent, Alankit Assignments Limited, confirming the dematerialization of securities during the quarter. The securities were verified, mutilated, and cancelled, with the...
Omkar Pharmachem has announced a board meeting on which approved the appointment of Mrs. Surjeet Kaur as an Additional Director and Non-Executive Woman Independent Director for five years, subject to shareholders’ approval. This appointment fills the vacancy created by the completion of Mrs. Mamta Pachauri’s two consecutive five-year terms as...
Omkar Pharmachem has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025. The company reported total income of Rs. 54.22 lakh for the year, with a net profit of Rs. 20.09 lakh, improving from a loss in the previous quarter. Cash...
Omkar Pharmachem Limited has announced its Annual Secretarial Compliance Report for the financial year 2024-25, issued by Maulik Bhavsar & Associates. The report confirms full compliance with applicable SEBI regulations and listing obligations during the year, with no deviations or non-compliances observed. All required policies have been adopted and updated...
